Alternative therapies for mild infections could help combat antibiotic resistance. Resistance to antibiotics poses a serious and sometimes deadly challenge to the treatment of severe bacterial infections. Researchers propose that development of alternative therapies for mild infections could help slow the development and spread of antibiotic resistance. Source 8o.
Supercharged antibiotics could turn tide against superbugs. An old drug supercharged by researchers has emerged as a new antibiotic that could destroy some of the world's most dangerous superbugs. The supercharge technique potentially could revitalize other antibiotics. Source 9t.
Inappropriate antibiotic prescribing differs by patient age, insurance, race. A patient's age and race are associated with risk of receiving an unneeded antibiotic prescription for upper respiratory conditions caused by viruses, according to a new study. Additionally, the study found that advanced practice providers, such as nurse practitioners and physician assistants, are 15 percent more likely than physician providers to prescribe antibiotics to adults. Source 1h.
No progress seen in reducing antibiotics among outpatients. Despite public health campaigns aimed at reducing unnecessary prescriptions for antibiotics, the drugs continue to be prescribed at startlingly high rates in outpatient settings, according to a new study. The researchers found that 98 million outpatient antibiotic prescriptions were filled by 39 million people from 2013 to 2015. Moreover, the researchers found no decline in the overall antibiotic prescription rate during that time. Source 2j.
First proof a synthesized antibiotic is capable of treating superbugs. A 'game changing' new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time -- and could lead to the first new class of antibiotic drug in 30 years. Source 4j.
Being able to create antibiotics with synthetics could mean the end of all infectious diseases but it would have to be an ongoing process because of mutations.
Medical Level: Health 101 / Health Participation: 3 0.3%